ARCA biopharma Inc

NAS:ABIO (USA)  
$ 3.27 +0.09 (+2.83%) 04:00 PM EST
At Loss
P/B:
1.28
Market Cap:
$ 47.42M
Enterprise V:
$ 8.89M
Volume:
294.96K
Avg Vol (2M):
2.17M
Also Trade In:
Volume:
294.96K
At Loss
Avg Vol (2M):
2.17M

Business Description

Description
ARCA biopharma Inc is a clinical-stage biopharmaceutical company applying a precision medicine approach to the development and commercialization of targeted therapies for cardiovascular diseases. The company's product candidates are rNAPc2 as a potential treatment for COVID-19, the disease syndrome caused by the SARS-CoV-2 virus, and potentially other viral diseases and Gencaro for the treatment of atrial fibrillation, or AF, in patients with chronic heart failure, or HF. rNAPc2 targets COVID-19 patients with biomarker evidence of coagulopathy, while Gencaro is being developed for patients who have a genotype that identifies a drug target associated with heightened efficacy.
Name Current Vs Industry Vs History
Cash-To-Debt 183.49
Equity-to-Asset 0.98
Debt-to-Equity 0.01
Debt-to-EBITDA -0.03
Interest Coverage N/A
N/A
N/A
Piotroski F-Score 4/9
0
1
2
3
4
5
6
7
8
9
WACC vs ROIC
WACC
ROIC
Name Current Vs Industry Vs History
5-Day RSI 73.45
9-Day RSI 77.97
14-Day RSI 78.69
6-1 Month Momentum % -16.95
12-1 Month Momentum % -15.58

Liquidity Ratio

Name Current Vs Industry Vs History
Current Ratio 59.01
Quick Ratio 59.01
Cash Ratio 58.76

Dividend & Buy Back

Name Current Vs Industry Vs History
3-Year Average Share Buyback Ratio -14.9
Shareholder Yield % 0.18
Name Current Vs Industry Vs History
ROE % -13.59
ROA % -13.13
ROIC % -1508.68
ROC (Joel Greenblatt) % -2347.49
ROCE % -18.46

Financials (Next Earnings Date:2024-04-24 Est.)

ABIO's 30-Y Financials
Income Statement Breakdown
No Enough Data
Balance Sheet Breakdown
No Enough Data
Cashflow Statement Breakdown
No Enough Data

Historical Operating Revenue by Business Segment

Historical Operating Revenue by Geographic Region

5-Step DuPont Analysis as of
No Enough Data

Guru Trades

See Details
To

Insider Trades

See Details
To

Gurus Latest Trades with NAS:ABIO

No Available Data

Peter Lynch Chart

Y-axis scale:
Interactive Chart
To

Performance

Dividend
Log
Bar
To

Annualized Return %  

Symbol
1 Week
1 Month
3 Months
6 Months
YTD
1 Year
3 Years
5 Years
10 Years

Total Annual Return %  

Symbol
2024
2023
2022
2021
2020
2019
2018
2017
2016
2015

ARCA biopharma Inc Executives

Details

GF Value

Valuation Chart

Year:

Analyst Estimate

Key Statistics

Name Value
Revenue (TTM) (Mil $)
EPS (TTM) ($) -0.37
Beta -0.03
Volatility % 18.28
14-Day RSI 78.69
14-Day ATR ($) 0.205175
20-Day SMA ($) 2.3765
12-1 Month Momentum % -15.58
52-Week Range ($) 1.56 - 3.88
Shares Outstanding (Mil) 14.5

Piotroski F-Score Details

Year:
Component Result
Piotroski F-Score 4
Positive ROA
Positive CFROA
Higher ROA yoy
CFROA > ROA
Lower Leverage yoy
Higher Current Ratio yoy
Less Shares Outstanding yoy
Higher Gross Margin yoy
Higher Asset Turnover yoy

ARCA biopharma Inc Filings

Filing Date Document Date Form
No Filing Data

ARCA biopharma Inc Stock Events

Financials Calendars
Event Date Price($)
No Event Data

ARCA biopharma Inc Frequently Asked Questions

What is ARCA biopharma Inc(ABIO)'s stock price today?
The current price of ABIO is $3.27. The 52 week high of ABIO is $3.88 and 52 week low is $1.56.
When is next earnings date of ARCA biopharma Inc(ABIO)?
The next earnings date of ARCA biopharma Inc(ABIO) is 2024-04-24 Est..
Does ARCA biopharma Inc(ABIO) pay dividends? If so, how much?
ARCA biopharma Inc(ABIO) does not pay dividend.

Press Release

Subject Date
No Press Release

Headlines

See More
  • 1
No news.
  • 1